T he vagus and sympathetic nerves link the heart to the central nervous system, carrying information from the heart over neural afferents and to the heart over neural efferents. Although it is generally well accepted that the autonomic nervous system can promote, precipitate, or prevent the development of cardiac arrhythmias, the mechanisms by which this transpires are incompletely understood. Several excellent recent reviews provide an overall discussion of the role of the autonomic nervous system and the genesis of cardiac arrhythmias.12 This review will focus on selected recent observations concerning autonomic innervation of the heart, the effects of myocardial ischemia and infarction on such innervation, and how some of these changes can modulate the development of cardiac arrhythmias.
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Autonomic Innervation of Heart Extracardiac Nerves Numerous studies to determine extracardiac neural innervation to the heart reveal that although significant overlap and complex patterns exist, in general autonomic neural input to the heart exhibits some degree of "sidedness." The right sympathetic and vagus nerves affect the sinus node more than the atrioventricular (AV) node, whereas the left sympathetic and vagus nerves affect the AV node more than the sinus node. Precise points of entry of parasympathetic nerves to the sinus and AV nodal regions have recently been described.3 On the right, vagal input to the superior atrial and sinus nodal regions is by neural projections along the superior vena cava-right atrial junction, azygos vein, right pulmonary vein complex, and dorsal surfaces of the common pulmonary vein complex. On the left, vagal input to the sinus nodal region is quantitatively less, but the pathways of innervation are similar to those on the right. Both right and left vagal fibers to the AV node enter the heart at the junction of the inferior vena cava and inferior left atrium and can be eliminated by excision of the triangular fat pad located at this junction. Pathways are so discrete that vagal fibers to the sinus or AV nodes can be selectively interrupted, with preservation of sympathetic innervation. 3 Such interruption can result in denervation supersensitivity to acetylcholine.4 Sympathetic fibers to the canine sinus node on the right are primarily from the right stellate cardiac nerve, which follows the superior vena cava and azygos vein to the pulmonary plexus and right atrium. On the left, the ventrolateral nerve courses laterally over the aorta and pulmonary artery where it receives branches from the recurrent laryngeal nerve and provides the major sympathetic innervation to the AV node. [5] [6] [7] Most efferent sympathetic impulses are transmitted to the canine ventricles by way of the ansae subclaviae, branches of the right and left stellate ganglia. The sympathetic innervation to the ventricle follows a course along the dorsal wall of the common pulmonary artery into the plexus supplying the main left coronary artery. The sympathetic nerves are distributed to the myocardium in superficial epicardial layers,8-11 primarily along coronary arterial pathways, and then penetrate the myocardium. On the right side, the major route to the heart is the recurrent cardiac nerve; on the left, the major route is the ventrolateral cardiac nerve. Although regional differences in norepinephrine and choline acetyltransferase concentrations occur between and within cardiac chambers12-'5 and individual cardiac nerves preferentially innervate relatively localized parts of the ventricles, 16-20 in (Figure 2) . In contrast to the effects of hexamethonium, tetrodotoxin (5 MM), a sodium channel blocker that interrupts axonal neurotransmission, when instilled in the pericardial space suppresses changes in refractoriness induced by both efferent vagal and ansae subclaviae stimulation (Figure 2 ) but does not affect changes in refractoriness induced by intravenous administration of norepinephrine or methacholine (not shown). These data indicate that tetrodotoxin instilled into the pericardial sac inhibits both efferent vagal and sympathetic neurotransmission but does not prevent the effector cell from responding to exogenous agonists. Thus, the site of action of tetro-LV by guest on April 1, 2017 http://circ.ahajournals.org/ Downloaded from dotoxin must be presynaptic; therefore, both vagal and sympathetic axons must at some point be located superficially during their course in the heart. These studies suggest that substances in the pericardial fluid, whether normally secreted or present due to disease, can modulate autonomic neural transmission to the heart. For example, the pericardium normally synthesizes prostaglandins, and under certain circumstances, such as increased myocardial work and oxygen consumption, substantial release of pericardial prostaglandin occurs. We have found recently that prostaglandins instilled into the pericardial sac or secreted into the pericardial fluid as a response to pericardial introduction of arachidonic acid produce an antisympathetic action and reduce the shortening of sinus cycle length, atrium-His conduction (AH interval), and refractoriness of the right and left ventricular myocardium induced by ansae subclaviae stimulation. Pericardial prostaglandins also prevent intra-aortic angiotensin II (Ang II) (30 ng/kg/min) from augmenting the effects of ansae subclaviae stimulation on these variables ( Figure 3 ). Epicardial superfusion with arachidonic acid plus indomethacin (1 ,g/ml) eliminates the prostaglandin increase and restores the electrophysiological responses to ansae subclaviae stimulation and Ang II infusion. Because epicardial superfusion with prostaglandin E2 or prostacyclin solution does not blunt the shortening of refractoriness induced by intravenous infusion of norepinephrine, the actions of pericardial prostaglandin are more likely due to a prejunctional modulation of cardiac sympathetic neurotransmission than to an alteration in postjunctional responsiveness.31
These data offer the possibility that an increased concentration of prostaglandins in the pericardial fluid in response to various stimuli may constitute a physiological negative-feedback control mechanism that regulates efferent sympathetic stimulation of the heart. Thus, when efferent sympathetic input to the heart is heightened or plasma catecholamines are increased, the pericardium could produce prostaglandin 12 and other prostaglandins, which would bathe the cardiac sympathetic nerves Myocardial ischemia or infarction has been shown to interrupt cardiac reflexes44 soon after the onset of coronary occlusion.45 Several minutes after creating transmural myocardial ischemia, the sympathetic reflex elicited from the epicardium of the ischemic area or apical to it becomes interrupted or attenuated when the myocardial blood flow in the epicardial test site decreases to approximately 40% or less of the control value. In contrast, nontransmural ischemia does not attenuate the epicardial sympathetic reflex but does attenuate the vagal vasodepressor response, as would be expected from the functional pathways described previously (Figure 1) . A 15-minute coronary occlusion followed by reperfusion produces reversible attenuation of vagal epicardial reflexes. Loss of these reflex responses so quickly after the onset of ischemia and return with reperfusion suggests initial functional neural impairment.
Thus, although it is well known that ischemia triggers cardiac reflexes,33-42 the data given above indicate that ischemia can also inhibit them. Therefore, the resultant physiological response may be a balance between inhibiting and activating actions of ischemia and may also be anatomically determined. For example, reflex activation may occur when it originates at ischemic sites in the basal or lateral borders of the ischemic zone, whereas the response originating at more apical locations may be inhibited. Perhaps reflex activation and inhibition have different time courses or different responses to transmural or nontransmural ischemic locations or to mechanosensitive or chemosensitive stimulation.
One subject of special interest is painless ischemia.46 Because afferent sympathetic fibers appear to mediate cardiac pain sensation, it is possible that some patients have a form of "autodenervation." Ischemia could interrupt afferent neurotransmission with elimination of pain perception. Recovery of neurotransmission would occur with reperfusion, so that another episode of ischemia, perhaps localized differently (e.g., sparing the epicardium), might then produce pain in the same patient. A sensory neuropathy has been used to explain altered anginal perceptual threshold in diabetics47 SYMPATHETIC DENERVATION 17 (12) 13 (11) 10 (6) 7 (7) 17 (12) 12 (6) 018) 10 function, probably by affecting neural transmission over axons located within the zone of ischemia or infarction, and produces efferent sympathetic and vagal denervation at noninfarcted sites apical to that zone ( Figure 4 ).48-50 Myocardium within the ischemic area may become denervated.51 As predicted from the schematic in Figure 1 , a subendocardial infarction that spares the epicardium interrupts vagal innervation but not sympathetic transmission. [48] [49] [50] 52 The noninfarcted myocardial rim overlying a subendocardial infarction also has a transiently depressed response to sympathetic nerve stimulation, possibly due to local factors released by the adjacent infarct. 53 Heterogeneous loss of functional efferent sympathetic innervation in noninfarcted apical sites occurs as early as 5-20 minutes after transmural ischemia created by coronary occlusion, with more complete denervation progressing with time. Some sites may undergo partial denervation initially, which progresses with time. 49 Of interest, the activity of tyrosine hydroxylase, a neurochemical marker for sympathetic innervation, decreases significantly in the ischemic left ventricle only after about 5 hours of ligation of the left anterior descending coronary artery. 54 Ischemia-produced efferent vagal denervation follows a similar time course as that of efferent sympathetic denervation.49 However, the activity of the enzyme critical for the synthesis of acetylcholine, choline acetyltransferase, does not decrease significantly until many hours after coronary ligation. 54 From these observations, it appears likely that early denervation is due to functional changes in neural activity with measurable decreases in transmitter concentration or enzyme activity lagging behind and following the onset of actual tissue damage as the infarction develops and progresses over time. The cardiac response to ischemia or infarction is also influenced by the "myocardial history." For example, four 5-minute episodes of coronary occlusion and reperfusion dramatically limit infarct size of the myocardium that is later subjected to 40 minutes of sustained ischemia, compared with myocardium that did not experience prior ischemia. 55 Although the mechanism of this protective effect of preconditioning ischemia is unknown, one hypothesis is that repeated episodes of ischemia regionally deplete catecholamines so that the final ischemia takes place in "sympathectomized" myocardium that can withstand the effects of ischemia better than ischemic myocardium with a normal catecholamine content. 56 In reality, the opposite occurs. Preconditioning ischemia without an increase in collateral blood flow to the ischemic myocardium actually preserves the efferent sympathetic response during the first hour of the subsequent sustained ischemia and preserves the efferent vagal response for at least 3 hours.57 Thus, the concept of regional sympathectomy does not explain the basis of preconditioning ischemia. However, understanding the mecnanism might provide insight into how the heart can be made more resistant to the effects of ischemia and related arrhythmias.
Mechanisms of Denervation Caused by Ischemia or Infarction
Initial loss of vagal and sympathetic neural responsiveness after acute myocardial ischemia is probably due to functional derangement of nerve action, as suggested above, rather than to structural changes. Because the denervated myocardium responds normally to infused norpinephrine, postjunctional target cell dysfunction is not likely.48,58 Prejunctional altered neural function may be due to ischemic changes in the nerves themselves or to the fact that the nerves lie in ischemic myocardium where the pH may be 6.8 or less, extracellular K' may be 12 mM or higher,59 and Po2 is less than 50 mm Hg. In addition, adenosine60 and other substances released by the ischemic myocardium may alter neural function.
Several of these possibilities have been tested.58 If the diagonal branch of the left anterior descending coronary artery is occluded but perfused with hypoxic normal Tyrode's solution (i.e., ischemia is still present but without buildup of ischemic metabolites), acute efferent sympathetic denervation of apical myocardium does not occur. On the other hand, if the occluded artery is perfused by a hypoxic Tyrode's solution containing 12 mM K' and 10 gM adenosine (pH 6.8), apical denervation promptly results. When these substances are instilled into the pericardial cavity (i.e., exposing the epicardial segments of these nerves to a superfusion of several metabolites found in the ischemic myocardium while avoiding any interruption in blood flow), similar denervation responses result. Thus, accumulation of metabolites in the ischemic myocardium through which the nerves pass is sufficient to produce neural dysfunction in myocardium apical to the ischemic site. Ischemia of the nerves themselves is not necessary. Of course, axonal ischemia in addition to neural modulation by accumulation of other ischemic metabolites is not excluded by this study and tion still further.58 may impair neural funcDenervation Supersensitivity, Arrhythmogenesis, and Reinnervation Tissue deprived of its nerve supply responds in an exaggerated fashion to certain agents, a phenomenon called "denervation supersensitivity."61,62 Sympathetic supersensitivity, manifest by an exaggerated shortening of refractoriness during both norepinephrine and isoproterenol infusions with an upward and leftward shift in the dose-response curves, occurs in apical denervated regions of the left ventricle ( Figure  5 ).63,64 The mechanism responsible for this type of supersensitivity is not clear because there is no difference in the density of f-adrenergic receptors ( [1251]-cyanopindolol) in denervated apical compared with normal basal myocardium. P-Adrenoceptor coupling (GTP plus isoproterenol-stimulated adenylate cyclase activity) is slightly but not significantly greater in the apical than in the basal region. Further, muscarinic modulation of :-receptor coupling (oxotremorine attenuation of GTP plus isoproterenol-stimulated adenylate cyclase activity) is not significantly different between apical and basal sites. However, the fact that isoproterenol also produces a supersensitive response suggests a postjunctional mechanism.63,64 uating the effects of denervation supersensitivity on dispersion of refractoriness, conduction changes, or other electrophysiological properties.
Regional sympathetic denervation and supersensitivity could also modulate drug actions and cause the drugs to affect the myocardium heterogeneously. Such changes could provide another proarrhythmic mechanism. 67 
Sympathetic Scintigraphy
Because efferent denervation produced by epicardial phenol application or transmural infarction is postganglionic, reinnervation most likely occurs. We investigated whether`231-labeled metaiodobenzylguanidine (MIBG), a guanethidine analogue taken up by sympathetic nerve terminals,68 could provide a scintigraphic image that would detect apical sympathetic denervation and possible reinnervation.69 Dogs underwent MIBG imaging at various times after phenol application or transmural myocardial infarction. The results of MIBG scintigraphy were then correlated with electrophysiological responses obtained during ansae subclaviae stimulation and norepinephrine infusion to establish the presence of neural denervation, reinnervation, and supersensitivity. Thallium images were obtained concurrently to outline areas of normal blood flow and cell viability. Apical defects in the MIBG scan, which were associated with either normal perfusion by thallium or a thallium defect that was smaller than the MIBG defect, were found consistently in dogs that had apical sympathetic denervation. Figure 7 demonstrates findings typical for the latex infarction model. Figure 7A shows a preoperative left lateral MIBG image, whereas an anteroapical defect is evident in Figure 7B (arrows) 7 weeks postinfarction. Figure 7C shows the corresponding left lateral image obtained 14 weeks postinfarction showing essentially complete resolution of the defect, consistent with reinnervation. Circumferential myocardial activity curves are shown in Figure 7D . The preoperative and reinnervation curves are parallel, whereas the 7 weeks postoperative curve derived from Figure  7B shows decreased activity beginning at 1800 and corresponding to an anteroapical defect. These findings support the image interpretation of denervation 7 weeks after infarction followed by reinnervation 14 weeks after infarction.
For all images, the results of MIBG scintigraphy correlated accurately with the presence of denervation and reinnervation established by neuroelectrophysiological testing. Supersensitive refractory period shortening in response to norepinephrine infusion was present after denervation and persisted for more than 3 weeks after scintigraphic and electrophysiological evidence of reinnervation. 69 This study69 demonstrates that regional sympa- (Figure 8 ).70°71 We found that 10 of 12 patients with spontaneous ventricular tachyarrhythmias after myocardial infarction exhibited regions of thallium-201 uptake indicating viable perfused myocardium, with no MIBG uptake. Such a finding is consistent with sympathetic denervation. One patient had frequent episodes of nonsustained ventricular tachycardia induced at exercise testing that was eliminated by f3-adrenoceptor blockade. Eleven of the 12 patients had ventricular tachycardia induced at electrophysiological study both before and after metoprolol administration. Sympathetic denervation was also detected in two of seven postinfarction patients without ventricular arrhythmias. This study70 provides evidence that regional sympathetic denervation occurs in humans after myocardial infarction and can be detected noninvasively by comparing MIBG and 20`T1 images. Although the presence of sympathetic denervation may be related to the onset of spontaneous ventricular tachyarrhythmias in some patients, it does not appear to be related to sustained ventricular tachycardia induced at electrophysiological study.
It is also possible to use MIBG to demonstrate noninvasively the disruption of myocardial sympathetic innervation in humans associated with a variety of disease states, such as during myocardial ischemia,72 in patients with dilated cardiomyopathy73-75 or hypertrophic cardiomyopathy,76 and after cardiac transplantation. 77 We have found no cardiac sympathetic neural uptake of MIBG shortly after cardiac transplantation ( Figure 9 ). MIBG scans in patients with arrhythmias directly attributable to sympathetic abnormalities such as the idiopathic long QT syndrome or dysautonomias might shed additional light on the pathogenesis of arrhythmias in these disease states. We found that MIBG scans were normal in one patient with the long QT syndrome and a family history of syncope and sudden death ( Figure 10 ) and in a 26-year-old female patient with the long QT syndrome who had been resuscitated from ventricular fibrillation, but the scans were abnormal in two of three patients with hypertrophic cardiomyopathy and of the regional denervation shown by the MIBG
Conclusions
In recent years, new information about extracardiac and intracardiac pathways has helped explain the effects of ischemia or infarction on cardiac neural innervation and the potential role the interaction between ischemia or infarction and the autonomic nervous system exerts on arrhythmia development. Use of modern imaging techniques may extend these concepts to patients and further delineate the mechanisms by which neural discharge affects arrhythmogenesis and sudden cardiac death.
